Germinal Peptide

生发肽

Report date: 2024/08/08 17:09:54
NME

Base Information

Drug NameGerminal Peptide
Drug Alias NameZKY-001ZK-003
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionThymosin Beta-4 agonists
TargetsThymosin Beta-4
Therapy Area/IndicationsCorneal Endothelial Cell LossFuchs' Endothelial DystrophyCorneal Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZhaoke Pharmaceutical (Hefei) Co LtdLee'S Pharmaceutical (Hk) Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhaoke Pharmaceutical (Hefei) Co LtdZhaoke (Guangzhou) Ophthalmology Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCorneal Endothelial Cell LossFuchs' Endothelial DystrophyCorneal Diseases +[4] 
Inactive IndicationsXerophthalmia

Other Information

ATC CodeN/A
Related LinksN/A